CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

XLOXilio Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $9.05 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$52.33M
CountryUSA
RECENT INSIDER TRADES
  • 2026-03-30 · Shannon James Samuel (Director) · BUY
  • 2026-02-17 · GILEAD SCIENCES, INC. (10% Owner) · BUY
  • 2026-01-05 · Frankenfield Christopher James (Chief Financial Officer) · SELL
  • 2026-01-05 · Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING) · SELL
  • 2025-06-18 · Shannon James Samuel (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders34
Shares held7,736,703
Value$36.22M
Percent of shares outstanding133.79%
As of quarter end2026-06-30
RECENT NEWS
  • XLO: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • Xilio Therapeutics appoints Yariv J. Houvras as Chief Medical Officer
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Xilio Therapeutics, Inc. (XLO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit